Across 27 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by 정현호, Executive. Director active across 2 companies, notably 메디톡스. In total, 56 reports have been published. Activity tracked since 3 March 2026. The latest transaction was disclosed on 3 March 2026 (Purchase). Regulator: DART (FSS). The full history is accessible without signup.
Public sources indicate that 정현호 is the CEO of Medytox, and the company’s official site identifies him as CEO, with a governance page showing him as CEO and Chairman as of March 30, 2026. A Korean exchange filing dated July 6, 2021 also describes him as Medytox’s largest shareholder, reporting 1,212,899 shares, or 17.84%, and says the change reflected the dissolution of a special relationship after his resignation as a registered director. Sources: https://medytox.com/page/governance_structure_en?site_id=en